Clinical Trial

Compassionate Use of Ubamatamab

Available
View on ClinicalTrials.gov →
Summary
Provide Compassionate Use of Ubamatamab
Trial Details
NCT Number NCT07502716
Lead Sponsor Regeneron Pharmaceuticals
Conditions Renal Medullary Carcinoma (RMC), Epithelioid Sarcoma
Updated on ClinicalTrials.gov 2026-03-31